Literature DB >> 30964345

Respiratory Protection Against Emerging Infectious Diseases: Face Masks, Respirators, and Tools for Choosing Between Them.

Christopher K Brown1.   

Abstract

The scientific literature reflects considerable debate over which types of respiratory protective devices (RPDs) are appropriate for protecting workers against exposure to infectious bioaerosols, including during outbreaks of emerging diseases. Some evidence suggests that face masks may offer similar protection to respirators, while other studies have found marked disparities in the protectiveness of these types of devices. Previous reviews have called for more information, chiefly in the form of clinical trials, to better inform decision making about RPDs. However, alternative approaches to respirator selection, including control banding tools that match groups of similar hazards to appropriate control measures, may be useful in choosing RPDs for workers with potential bioaerosol exposures on the job. These tools, while offering more streamlined approaches to RPD selection, come with challenges of their own, including questions about how to allocate different RPDs to different workers. This article reviews arguments on both sides of the face mask-respirator divide and considers the use of control banding tools in the context of preparedness for serious emerging infectious disease outbreaks.

Keywords:  Infectious diseases; Occupational health; Personal protective equipment

Mesh:

Year:  2019        PMID: 30964345     DOI: 10.1089/hs.2018.0056

Source DB:  PubMed          Journal:  Health Secur        ISSN: 2326-5094


  2 in total

1.  Fabrication of a highly protective 3D-printed mask and evaluation of its viral filtration efficiency using a human head mannequin.

Authors:  Yuki Ohara; Junichi Kanie; Katsutoshi Hori
Journal:  HardwareX       Date:  2022-05-08

Review 2.  Use of powered air-purifying respirator(PAPR) as part of protective equipment against SARS-CoV-2-a narrative review and critical appraisal of evidence.

Authors:  Ana Licina; Andrew Silvers
Journal:  Am J Infect Control       Date:  2020-11-10       Impact factor: 2.918

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.